AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31

Azitra, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.07+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $1.38M
P/E (TTM): –
Dividend yield: –

Dividends

Azitra has not reported a dividend

No dividend per share appears in Azitra's annual filings since fiscal 2021.

Where these numbers come from

Parsed from the XBRL in Azitra's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-6.67 reverse split on Aug 21, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is AZTR.

Revenue growth-100.0% · median -37.0%

Company	Revenue	Growth
SKVI	$20.00K	0.0%
ADTX	$14.34K	-74.1%
AZTR	$0	-100.0%
SYBX	$0	–
GNLX	–	–
KPRX	–	–

Company

Next earnings (est.): Nov 11, 2026, after close
Exchange: NYSE
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 13
Held by institutions: 35.7%
Auditor: GRASSI & CO., CPAs, P.C.
SEC CIK: 1701478

Advertisement
300 × 250